絞り込み

16610

広告

Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia (T-PLL).

著者 Staber PB , Herling M , Bellido M , Jacobsen ED , Davids MS , Kadia TM , Shustov A , Tournilhac O , Bachy E , Zaja F , Porkka K , Hoermann G , Simonitsch I , Haferlach C , Kubicek S , Mayerhoefer M , Hopfinger G , Jaeger U , Dearden C
Blood.2019 Jul 10 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (2view , 0users)

Full Text Sources

T-cell prolymphocytic leukemia (T-PLL) is a rare, mature T-cell neoplasm with a heterogeneous clinical course. With the advent of novel treatment options that will potentially change the management of T-PLL patients it has become necessary to produce consensus guidelines for the design and conduct of clinical trials. The T-PLL International Study group (TPLL-ISG)set out to define standardized criteria for diagnosis, treatment indication, and evaluation of response. These criteria will facilitate comparison of results from clinical trials in T-PLL and will thus support clinical decision making as well as the approval of new therapeutics by healthcare authorities.
PMID: 31292114 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード